Abstract
The effects of 5-hydroxytryptamine (5-HT) on the cardiovascular system are complex and very variable [1], which is not surprising given that the amine can act directly on specific 5-HT receptors in the heart and blood vessels, inhibit transmitter release from adrenergic nerves, amplify the activity of mediators on vascular smooth muscle, displace noradrenaline from adrenergic nerve terminals, release endothelium-dependent relaxant factor(s), facilitate platelet aggregation, and, in addition, can also activate sensory receptors in the cardiopulmonary system and carotid bifurcation, thereby reflexly affecting the cardiovascular system [2, 3, 4]. This chapter focuses on certain sensors that are activated by 5-HT to cause reflex cardiovascular changes, and reviews what is known about the type(s) of 5-HT receptor involved in evoking these reflexes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Page IH, McCubbin JW (1953): The variable arterial pressure response to serotonin in laboratory animals and man. Circ Res 1: 354–362.
Paintal AS (1955): Impulses in vagal afferent fibres from specific pulmonary deflation receptors. The response of these receptors to phenyl diguanide, potato starch, 5-hydroxytryptamine and nicotine, and their role in respiratory and cardiovascular reflexes. Q J Exp Physiol 40: 89–111.
Paintal AS (1973): Sensory mechanisms involved in the Bezold-Jarisch reflex. Australian J Exp Biol & Med Sci 51:3–15.
Hollenberg NK (1988): Serotonin and vascular responses. Ann Rev Pharmacol Toxicol 28: 41–59.
Page IH (1952): The vascular action of natural serotonin, 5- and 7-hydroxytryptamine and tryptamine. J Pharmacol Exp Ther 105: 58–73.
Salmoiraghi GC, Page IH, McCubbin JW (1956): Cardiovascular and respiratory response to intravenous serotonin in rats. J Pharmacol Exp Ther 118: 477–481.
Black AMS, Comroe JH Jr, Jacobs L (1972): Species difference in carotid body response of cat and dog to dopamine and serotonin. Am J Physiol 223: 1097–1102.
Daly M de B (1985): Chemoreceptor reflexes and cardiovascular control. Acta Physiol Pol 36: 4–20.
Heymans C, Neil E (1958): ‘Reflexogenic areas of the cardiovascular system’, pp. 271. London, Churchill.
Ginzel KH (1975): The importance of sensory nerve endings as sites of drug action. NS Arch Pharmacol 288: 29–56.
Mancia G, Lorenz RR, Shepherd JT (1976): Reflex control of circulation by heart and lungs. Inter Rev Physiol Cardiovascular Physiol 11 9:111–144.
Paintal AS (1977): Effects of drugs on chemoreceptors, pulmonary and cardiovascular receptors. Pharmac Ther Bull 3: 41–63.
Donald DE, Shepherd JT (1978): Reflexes from the heart and lungs: physiological curiosities or important regulatory mechanisms. Cardiovasc Res 12: 446–469.
Thoren P (1979): Role of cardiac vagal C-fibres in cardiovascular control. Rev Physiol Biochem Pharmacol 86: 1–94.
Dawes GS, Mott JC, Widdicombe JG (1951): Respiratory and cardiovascular reflexes from the heart and lungs. J Physiol 115: 258–291.
Ginzel KH (1958): The effects of 5-hydroxytryptamine on peripheral receptors of cardiovascular and respiratory reflexes, pp. 131–135 in: Lewis GP (ed.), 5-Hydroxytryptamine. London: Pergamon.
Richardson BP, Engel G, Donatsch P, Stadler PA (1985): Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126 - 131.
Richardson BP, Engel G (1986): The pharmacology and function of 5-HT3 receptors. Trends in Neurosci 9: 424–428.
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylencharane EJ, Richardson BP, Saxena PR (1986): Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol 25: 563 - 576.
Nishi K (1975): The action of 5-hydroxytryptamine on chemoreceptor discharges of the cat’s carotid body. Br J Pharmacol 55: 27–40.
Sapru HN, Krieger AJ (1977): Effect of 5-hydroxytryptamine on the peripheral chemoreceptors in the rat. Res Comm Chem Path Pharmacol 16: 245–250.
Sapru HN, Krieger AJ (1977): Carotid and aortic chemoreceptor function in the rat. J Appl Physiol 42: 344–348.
Chiocchio SR, Biscardi AM, Tramezzani JH (1967): 5-Hydroxytryptamine in the carotid body of the cat. Science 158:790–791.
McQueen DS, Mir AK (1984): Changes in carotid body amine levels and effects of dopamine on rats treated neonatally with capsaicin. Br J Pharmacol 83: 909–918.
Gronblad M, Liesi P, Rechardt L (1983): Serotonin-like immunoreactivity in rat carotid body. Brain Res 276: 348–350.
Perrin DG, Chan W, Cutz E, Madapallimattam A, Sole MJ (1986): Serotonin in human infant carotid body. Experientia 42: 562–564.
McQueen DS (1983): Pharmacological aspects of putative transmitters in the carotid body, pp. 149–196 in: Acker H, O’Regan RG (ed.), Physiology of the peripheral arterial chemoreceptors. Amsterdam: Elsevier.
McQueen DS, Ungar A (1971): On the direct and crossed components of reflex responses to stimulation of the carotid body chemoreceptors in the dog. J Physiol 219: 1–16.
Skinner SL, Whelan RF (1962): Carotid body stimulation by 5-hydroxytryptamine in man. J Physiol 162: 35–43.
Bisgard GE, Mitchell RA, Herbert DA (1979): Effects of dopamine, norepinephrine and 5-hydroxytryptamine on the carotid body of the dog. Resp Physiol 37: 61–80.
Kirby GC, McQueen DS (1984): Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine. Br J Pharmacol 83: 259–269.
Eyzaguirre C, Koyano H (1965): The effects of some pharmacological agents on chemoreceptor discharges. J Physiol 178: 410–437.
Yoshioka M, Matsumoto M, Togashi H, Abe M, Tochihara M, Saito H (1987): The 5-hydroxytryptamine-induced increase in chemoreceptor afferent nerve discharge and its blockade by ICS 205-930 in the rat. Res Comm Psych Psych & Behaviour 12: 215–220.
Kirby GC, McQueen DS (1985): Effects of selective 5-hydroxytryptamine agonists on carotid body chemoreceptor discharge in anaesthetized cats. Br J Pharmac 86: 733 P.
McQueen DS, Mir AK (1988): Involvement of 5-HT3 receptors in responses of cat carotid body chemoreceptors to phenylbiguanide. J Physiol 401: 86 P.
Scholtysik G. (1987): Evidence for inhibition by ICS 205–930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. N-S. Arch. Pharmacol 335: 692–696.
Verberne AJM, Costa M, Lewis SJ, Louis WJ, Beart PM (1987): The N-Methyl-D-aspartate (NMDA) receptor antagonist MK-801, attenuates the Bezold-Jarisch reflex in the anaesthetized rat. Neuropharmacology 26: 1243–6.
Fortune DH, Ireland SJ, Tyers MB (1983): Phenylbiguanide minics the effects of 5-hydroxytryptamine on the rat isolated vagus nerve and superior cervical ganglion. Br J Pharmacol 79: 298 P.
Collins DP, Fortune DH (1983): Phenylbiguanide mimics the Bezold-Jarisch effect of 5-HT in the rat. Br J Pharmac 80: 570 P.
Fozard JR (1984): MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. N-S Arch Pharmacol 326: 36–44.
Richardson BP, Engel G, Dontasch P, Stadler PA (1985): Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126–131.
Ireland SJ, Tyers MB (1987): Pharmacological characterisation of 5-hydroxytryptamine- induced depolarization of the rat isolated vagus nerve. BrJPharmac 90: 229–238.
Paintal AS (1986): The significance of dry cough, breathlessness and muscle weakness. IndJ Tuberculosis 33: 51–55.
Armstrong DJ, Kay IS, Russell NJW (1986): The pulmonary chemoreflexes evoked by phenylbiguanide, diguanide and guanide. J Physiol 371: 115 P.
Armstrong DJ, Kay IS, Russell NJW (1986): MDL 72222 antagonizes the reflex tachypneoic response to miliary pulmonary embolism in anaesthetized rabbits. J Physiol 381: 13 P.
Sapru HN, Willette RN, Krieger AJ (1981): Stimulation of pulmonary J receptors by an enkephalin analog. J Pharm Exp Ther 217: 228–234.
Sicuteri F (1983): Is acute tolerance to 5-hydroxytryptamine opioid dependent? Its absence in migraine sufferers. Cephalagia 3: 187–190.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
McQueen, D.S. (1990). Cardiovascular reflexes and 5-hydroxytryptamine. In: Saxena, P.R., Wallis, D.I., Wouters, W., Bevan, P. (eds) Cardiovascular Pharmacology of 5-Hydroxytryptamine. Developments in CardioCardiovascular Pharmacology of 5-Hydroxytryptamine, vol 106. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0479-8_17
Download citation
DOI: https://doi.org/10.1007/978-94-009-0479-8_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6701-0
Online ISBN: 978-94-009-0479-8
eBook Packages: Springer Book Archive